“B5H7, a Morpholine Derivative of 23-Hydroxybetulinic Acid, Reverses Doxorubicin Resistance in HepG2/ADM”, J. Can. Res. Updates, vol. 3, no. 1, pp.  59–66, Jan. 2014, doi: 10.6000/1929-2279.2014.03.01.6.